TY - JOUR
T1 - Guía de práctica clínica para el diagnóstico y manejo inicial de artritis reumatoide en el Seguro Social del Perú (EsSalud)
AU - Salinas, Ariel
AU - Huaringa-Marcelo, Jorge
AU - Alfaro-Lozano, José
AU - Becerra-Chauca, Naysha
AU - Nieto-Gutierrez, Wendy
AU - Garcia-Gomero, David
AU - Jara, Jesús De la
AU - Calderón-Gallegos, Julia
AU - Flores, Cesar
AU - Taype-Rondan, Alvaro
AU - Timaná-Ruiz, Raúl
AU - Salvador-Salvador, Stefany
AU - Carrera-Acosta, Lourdes
AU - Gamboa-Cárdenas, Rocío
N1 - Publisher Copyright:
© 2021 Revista del Cuerpo Médico del HNAAA. All rights reserved.
PY - 2021/10
Y1 - 2021/10
N2 - Background: Rheumatoid Arthritis (RA) has adverse health consequences, its early diagnosis and optimal management require recommendations based on high quality evidence adapted to each health system. Objective: To provide evidence-based clinical recommendations for the diagnosis and initial management of RA. Material and Methods: A Guideline Development Group (GDG) was established, including medical specialists and methodologists. The GDG formulated 10 clinical questions to be answered by this CPG. Systematic searches of published evidence in PubMed and CENTRAL were performed during December 2017 and July 2019 (including systematic reviews and -when it was considered pertinent- primary studies) were conducted. The evidence of the highest quality for answering each of the posed clinical questions was selected. The quality of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology which was used in periodic work meetings by the GDG to review the evidence and formulate the recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution N° 132 – IETSI – ESSALUD – 2019. Results: This CPG addressed 10 clinical questions, divided into two topics: diagnosis and management. Based on these questions, 16 recommendations (5 strong and 11 weak), 28 points of good clinical practice, and 3 flowcharts were formulated. Conclusion: This article summarizes the methodology and evidence-based conclusions from the CPG for the diagnosis and initial management of RA in EsSalud.
AB - Background: Rheumatoid Arthritis (RA) has adverse health consequences, its early diagnosis and optimal management require recommendations based on high quality evidence adapted to each health system. Objective: To provide evidence-based clinical recommendations for the diagnosis and initial management of RA. Material and Methods: A Guideline Development Group (GDG) was established, including medical specialists and methodologists. The GDG formulated 10 clinical questions to be answered by this CPG. Systematic searches of published evidence in PubMed and CENTRAL were performed during December 2017 and July 2019 (including systematic reviews and -when it was considered pertinent- primary studies) were conducted. The evidence of the highest quality for answering each of the posed clinical questions was selected. The quality of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology which was used in periodic work meetings by the GDG to review the evidence and formulate the recommendations, points of good clinical practice, and flowcharts. Finally, the CPG was approved with Resolution N° 132 – IETSI – ESSALUD – 2019. Results: This CPG addressed 10 clinical questions, divided into two topics: diagnosis and management. Based on these questions, 16 recommendations (5 strong and 11 weak), 28 points of good clinical practice, and 3 flowcharts were formulated. Conclusion: This article summarizes the methodology and evidence-based conclusions from the CPG for the diagnosis and initial management of RA in EsSalud.
KW - Arthritis
KW - Evidence-Based Medicine
KW - GRADE Approach
KW - Peru. (Source: DeCSBIREME)
KW - Practice Guideline
KW - Rheumatoid Arthritis
UR - http://www.scopus.com/inward/record.url?scp=85132612473&partnerID=8YFLogxK
U2 - 10.35434/rcmhnaaa.2021.144.1460
DO - 10.35434/rcmhnaaa.2021.144.1460
M3 - Artículo
AN - SCOPUS:85132612473
SN - 2225-5109
VL - 14
SP - 510
EP - 522
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 4
ER -